Gut's stromal tumors prognosis. A 36 cases study;Les tumeurs stromales du tube digestif: Evaluation pronostique d'une série de 36 cas

Annales de Pathologie

Volumn 16, Issue 1, 1996, Pages 27-32

  Ghnassia, J P ^a   Wagner, M ^b   Velten, M ^a  

^a Paul Strauss Comprehensive Cancer Center   (France)

^b Institut de Pathologie Strasbourg   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE TUMOR; MALE; MITOSIS; PROGNOSIS; STROMA;

ADULT; AGED; DIGESTIVE SYSTEM NEOPLASMS; EVALUATION STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MITOTIC INDEX; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RETROSPECTIVE STUDIES;

EID: 0029964618     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. MAZUR MT, CLARK HB. Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol 1983 ; 7 : 507-19
2. BEDOSSA P, MARTIN E. Quoi de nouveau sur les tumeurs conjonctives du tube digestif. Ann Pathol 1994 ; 14 : 350-6.
3. APPELMAN HD, HELWIG EB. Sarcomas of the stomach. Am J Clin Pathol 1977 ; 67 : 2-10.
4. SILVERBERG SG. Reproductibility of the mitosis count in the histologic diagnosis of smooth muscle tumors of the uterus. Hum Pathol 1976 ; 7 : 451-4
5. APPELMAN HD, HELWIG EB. Gastric epithelioid leiomyoma and leiomyosarcoma (leiomyoblastoma). Cancer 1976 , 38 : 708-28.
6. GARCIA RL, COLTRERA MD, GOWN AM Analysis of proliferating grade using anti-PCNA/cyclin monoclonal antibodies in fixed, ebedded tissue. Comparison with cytometric analysis. Am J Pathol 1989 ; 134 : 733-39.
7. HALL PA, LEVISON DA, WOODS AL, YU CCW, KELLOCK DB, WATKINS JA et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections : an index of cell proliferation with evidence of deregulated expression in some neoplasm. J Pathol 1990 ; 162 : 285-94.
8. RANCHOD M, KEMPSON RL. Smooth muscle tumors of the gastrointestinal tract and retroperitoneum A pathologic analysis of 100 cases. Cancer 1977 ; 39 : 255-62.
9. CUNNINGHAM RE, FEDERSPIEL BH, MCCARTHY WF, SOBIN LH, O'LEARY TJ. Predicting prognosis of gastrointestinal smooth muscle tumors. Role of clinical and histologic evaluation, flow cytometry and image cytometry. Am J Surg Pathol 1993 ; 17 : 588-94
10. FRANQUEMONT DW. Differentiation and risk assessment of gastrointestinal stromal tumors. Am J Clin Pathol 1995 ; 103 : 41-47.
11. EVANS H. Smooth muscle tumors of the gastrointestinal tract. A study of 56 cases followed for a minimum of 10 years. Cancer 1985 ; 56 : 2242-50.
12. BRAVO R, FRANCK R, BLUNDELL PA, MAC DONALD-BRAVO H Cyclin/PCNA is the auxiliary protein of DNA polymerase delta. Nature 1987 ; 326 : 507-19.
13. CELIS JE, BRAVO R, LARSEN PM, FEY SJ. Cyclin : A nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells. Leuk Res 1984 ; 8 : 143-57.
14. JAIN S, FILIPE MI, HALL PA, WASEEM N, LANE DP, LEVISON DA. Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. J Clin Pathol 1991 ; 44 : 655-9.
15. TAHAN SR, NEUBERG DS, DIEFFENBACH A, YACOUB L. Prediction of early relapse and shortened survival in breast cancer by proliferating cell nuclear (PCNA) score. Cancer 1993 ; 71 : 3552-9.
16. GHNASSIA JP, WAGNER M, GASSER B, WALTER PR. Tumeurs de la corticosurrénale. II-Evaluation pronostique d'une série de 12 cas par l'anticorps anti-PCNA. Ann Pathol 1993 ; 13 : 312-6.
17. BALVTON A, OCHANDO F, PAINCHAUD MH. Utilisation des microondes pour aviver ou restaurer les antigènes avant la réaction immunohistochimique. Ann Pathol 1993 ; 13 : 188-9.
18. CELIS JE, CELIS A. Cell-cycle-dependant variations in the distribution of the nuclear protein cyclin/proliferating cell nuclear antisen in cultured cells : subdivision of S phase. Proc Natl Acad Sci USA 1978 ; 82 : 3262-6.
19. HALL PA, COATES PJ, GOODLAD RA, HART IR, LANE DP. Proliferating cell nuclear antigen expression in non cycling cells may be induced by growth factors in vivo Br J Cancer 1994 ; 70 : 244-7.
20. AMIN MB, MA CK, LINDEN MD, KUBUS JJ, ZARBO RJ. Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumors Correlation with mitotic count and clinical outcome. Am J Clin Pathol 1993 ; 100 : 428-32.
21. YU CCW, FLETCHER CDM, NEWMAN PL, GOODLAD JR, BURTON JC, LEVISON DA. A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours. J Pathol 1992 ; 766 : 147-52.
22. SBASCHNIG RJ, CUNNINGHAM RE, SOBIN LH, O'LEARY TJ. Proliferating-cell nuclear antigen immunocytochemistry in the evaluation of gastrointestinal smooth muscle tumors. Modern Pathol 1994; 7 : 780-3.
23. STOUT AP. Bizarre smooth muscle tumors of the stomach. Cancer 1962 , 15 : 400-9.
24. BELL SW, KEMPSON RL, HENDRICKSON MR. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 1994 ; 18 : 535-58.
25. COOPER PN, QUIRKE P, HARDY GJ, DIXON MF. A flow cytometric, clinical, and histological study of stromal neoplasms of the gastrointestinal tract. Am J Surg Pathol 1992 ; 16 : 163-70.
26. KIMURA H, YONEMURA Y, KADOYA N, KOSAKA T, MIWA K, MIYAZAKI I et al. Correlation between DNA ploidy and clinical features in smooth muscle tumors of the gastrointestinal tract. Ann Cell Pathol 1993 ; 5 : 331-8.
27. CUNNINGHAM RE, FEDERSPIEL BH, MCCARTHY WF, SOBIN LH, O'LEARY TJ. Predicting prognosis of gastrointestinal smooth muscle tumors. Role of clinical and histologic evaluation, flow cytometry, and image cytometry. Am J Surg Pathol 1993 ; 17 : 588-94.
28. MIETTINEN M, VIROLAINEN M, SARLOMO RIKALA M. Gastrointestinal stromal tumors-values of CD34 antigen in their identification and separation from true letomyomas and schwannomas Am J Surg Pathol 1995 ; 19 : 207-16.
29. MCCLAIN KL, LEACH CT, JENSON HB, JOSHI VV, POLLOCK BD, PARMLEY RT et al. Association of Epstein-Barr virus with letomyosarcomas on young people with AIDS. N Eng J Med 1995 ; 332 : 12-8